HBV-IN-23

Modify Date: 2024-01-10 18:52:28

HBV-IN-23 structure	Common Name	HBV-IN-23
	CAS Number	2413649-89-3	Molecular Weight	449.57
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₅H₂₇N₃O₃S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HBV-IN-23

HBV-IN-23 (Compound 5k) is an inhibitor of HBV DNA replication with an IC50 of 0.58 µM. HBV-IN-23 inhibits HBV DNA replication in both drug sensitive and resistant HBV strains. HBV-IN-23 shows anti-hepatocellular carcinoma cell (HCC) activities. HBV-IN-23 induces HepG2 cells apoptosis[1].

Name	HBV-IN-23

Description	HBV-IN-23 (Compound 5k) is an inhibitor of HBV DNA replication with an IC50 of 0.58 µM. HBV-IN-23 inhibits HBV DNA replication in both drug sensitive and resistant HBV strains. HBV-IN-23 shows anti-hepatocellular carcinoma cell (HCC) activities. HBV-IN-23 induces HepG2 cells apoptosis[1].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cancer Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV Signaling Pathways >> Cell Cycle/DNA Damage >> DNA/RNA Synthesis
Target	IC50: 0.58 µM (HBV DNA replication)[1]
References	[1]. Qiu J, et al. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents. Eur J Med Chem. 2020 Nov 1;205:112581.

Molecular Formula	C₂₅H₂₇N₃O₃S
Molecular Weight	449.57

HBV-IN-23

Use of HBV-IN-23

Names

HBV-IN-23 Biological Activity

Chemical & Physical Properties